NEU 0.35% $20.17 neuren pharmaceuticals limited

ann: neuren completes enrolment of second pati, page-9

  1. 312 Posts.
    lightbulb Created with Sketch. 2
    At this astonishing speed, the PHIII trial will be finished enrolment within a year. possibly on market within three years, and a MC of 3bil.
    OMG
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.